Sean Smith's most recent trade in QXO Inc. was a trade of 1,040,298 Restricted Stock Unit done . Disclosure was reported to the exchange on July 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QXO Inc | Sean Smith | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 1,040,298 | 1,040,298 | - | - | Restricted Stock Unit | |
| QXO Inc | Sean Smith | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 9.14 per share. | 25 Jul 2024 | 27,353 | 27,353 (0%) | 0% | 9.1 | 250,006 | Common Stock, par value $0.00001 per share |
| Neoleukin Therapeutics Inc | Sean Smith | Interim CFO, Prin Acct Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 5,000 | 22,960 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Sean Smith | Interim CFO, Prin Acct Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Sean Smith | Interim CFO, Prin Acct Off | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Aug 2023 | 1,323 | 21,637 (0%) | 0% | 0.6 | 818 | Common Stock |
| Neoleukin Therapeutics Inc | Sean Smith | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 12,500 | 19,276 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Sean Smith | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Sean Smith | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 01 Feb 2023 | 3,316 | 15,960 (0%) | 0% | 0.6 | 1,980 | Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.62 per share. | 01 Sep 2022 | 424,558 | 3,038,779 (1%) | 0% | 7.6 | 3,235,132 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 178,784 | 3,463,337 (1%) | 0% | 0 | Class A Common Stock | |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 102,236 | 3,329,435 (1%) | 0% | 0 | Class A Common Stock | |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.29 per share. | 12 Aug 2022 | 44,882 | 3,284,553 (1%) | 0% | 7.3 | 327,190 | Class A Common Stock |
| Neoleukin Therapeutics Inc | Sean Smith | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.54 per share. | 01 Aug 2022 | 51,371 | 3,227,199 (1%) | 0% | 6.5 | 335,966 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 220,000 | 3,278,570 (1%) | 0% | 0 | Class A Common Stock | |
| Neoleukin Therapeutics Inc | Sean Smith | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.64 per share. | 01 Mar 2022 | 11,973 | 3,058,570 (1%) | 0% | 8.6 | 103,447 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 11 Feb 2022 | 3,376 | 3,070,543 (1%) | 0% | 8.3 | 28,122 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.04 per share. | 01 Sep 2021 | 376,037 | 3,073,919 (1%) | 0% | 5.0 | 1,895,226 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. | 30 Jul 2021 | 60,226 | 3,449,956 (1%) | 0% | 5.2 | 313,777 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 331,577 | 3,510,182 (1%) | 0% | 0 | Class A Common Stock | |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.06 per share. | 01 Mar 2021 | 7,894 | 3,178,605 (1%) | 0% | 4.1 | 32,050 | Class A Common Stock |
| Permian Resources Corp | Sean R. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 12 Feb 2021 | 4,037 | 3,186,499 (1%) | 0% | 3.5 | 14,008 | Class A Common Stock |